Search form

You are here

Alzheimers



Alzheimer’s drug gets FDA panel’s backing, setting the stage for broader use

  • The FDA panel reviewed more recent data from an 1,800-patient study in which people taking the drug showed a modestly slower rate of decline on measures of memory, judgment and other cognitive tests
By AP ·

Riyadh to host conference on Alzheimer’s disease

By SPA ·

Teetotallers, like big drinkers, more prone to dementia: study

By AFP ·

Latest updates

World Cup risks being ‘stage for repression’: Amnesty
Trump says he wants Iran’s oil, could seize Kharg Island, FT reports
Saudi king, crown prince offer condolences on death of Algeria’s former president Zeroual
Ukrainian drones kill one, damage homes, industry in southern Russia’s Taganrog
King Felipe VI reaffirms Spain’s solidarity with Saudi Arabia amid attacks

Recommended

Middle-East
All eyes on Islamabad as Saudi Arabia, Egypt, Turkiye and Pakistan intensify efforts to contain Iran conflict
Middle-East
Is Israel moving toward a new occupation in Lebanon?
Middle-East
Analysis: GCC received 83% of Iran’s missiles and drones compared to 17% launched at Israel
Smoke rises from a high-rise building following a drone attack in Kuwait City on March 8, 2026. (AFP)

Search form

Print Edition
Read pdf version Subscribe now
© 2026 SAUDI RESEARCH & PUBLISHING COMPANY, All Rights Reserved And subject to Terms of Use Agreement.